Evidence map›Paper›PMID 24029832›Full record

ArticleJAMA ophthalmology2013

Novel compound heterozygous mutations resulting in cone dystrophy with supernormal rod response.

Tamara Lee Lenis, Elona Dhrami-Gavazi, Winston Lee, Sri Krishna Mukkamala, Mirela Raluca Tabacaru, Lawrence Yannuzzi, Peter Gouras, Stephen H Tsang

Abstract readCase Reports
In one paragraph

Article in JAMA ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ophthalmic genetics · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tamara Lee LenisCleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.
Elona Dhrami-Gavazi
Winston Lee
Sri Krishna Mukkamala
Mirela Raluca Tabacaru
Lawrence Yannuzzi
Peter Gouras
Stephen H Tsang

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Toward mechanism- and gene-based therapies for retinal degenerationR01EY018213 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Stephen H Tsang · 2008 to 2026
$6.6M
NCI NIH HHS 5P30CA013696NCI NIH HHS P30 CA013696NEI NIH HHS 5P30EY019007NEI NIH HHS P30 EY019007NEI NIH HHS R01 EY018213Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationElectroretinographyFluorescein AngiographyHeterozygoteHumansMaleMiddle AgedOphthalmoscopyPotassium Channels, Voltage-GatedRetinitis PigmentosaTomography, Optical CoherenceVisual AcuityVisual Field TestsKCNV2 protein, humanPotassium Channels, Voltage-Gated

Identifiers

PMID24029832
PMCPMC4377131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.